Wisconsin hospitals filed 37% more lawsuits against patients from 2001 to 2018, study finds
Fierce Healthcare
DECEMBER 7, 2021
Wisconsin hospitals filed 37% more lawsuits against patients from 2001 to 2018, study finds. Tue, 12/07/2021 - 12:07.
2001 Related Topics 
REGiMMUNE Entered into a License Agreement with San Fu Biotech to Develop and Commercialize RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease
PharmaShots
APRIL 3, 2023
REGiMMUNE’s RGI-2001 is currently in P-III trial for the prophylaxis of aGVHD Ref: Businesswire | Image: Regimmune Related News:- Omega Therapeutics Entered into a Clinical Supply Agreement with Roche to Evaluate OTX-2002 for Hepatocellular Carcinoma
40 Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Number of ongoing US drug shortages reaches new high, pharmacist group says
Fierce Pharma
APRIL 11, 2024
as of 2024’s first quarter—the highest number recorded since ASHP began tracking shortage data back in 2001. . | The American Society of Health-System Pharmacists has released new data showing there were 323 drugs in shortage in the U.S.
131 
STAT+: Drug shortages reached a record high as 2023 drew to a close
STAT
APRIL 10, 2024
stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country. The number of ongoing and active drug shortages in the U.S.
Chemotherapy 143
143 
Opinion: I grew up in one of Africa’s largest informal settlements. Now I’m helping heal it
STAT
NOVEMBER 24, 2023
In 2001, at the age of 13, I had come to Kenya’s largest informal settlement on the outskirts of Nairobi with my sister. I had only lived in Kibera for 15 minutes when I saw a police officer and was arrested. But it would be years before I saw a real doctor. When we arrived at 3 a.m.,
127 
Opinion: STAT+: A California court is setting a dangerous precedent over drug development (or lack thereof) liability
STAT
FEBRUARY 13, 2024
In 2001, Gilead secured FDA approval of tenofovir disoproxil fumarate (TDF), one of first medicines to treat HIV — a product still on the market, despite the potential side effect of causing skeletal and kidney damage.
FDA 124
124 FDA 124
124 
Women in Science: Trinity Life Sciences’ Leslie Orne: ‘I love the energy and dynamism of consulting’
Outsourcing Pharma
JULY 26, 2023
Leslie Orne joined Trinity Life Sciences in 2001 and was recently appointed CEO and president of the fast-growing healthcare consultancy. She previously held the title of chief commercial officer (CCO) and president.
71 
Suicides and homicides among young Americans jumped early in the pandemic, study says
STAT
JUNE 15, 2023
The Centers for Disease Control and Prevention report examined the homicide and suicide rates among 10- to 24-year-olds from 2001 to 2021. The homicide rate for older U.S. Read the rest…
98 
Opinion: STAT+: 3 keys to successful biopharma-academia drug development collaborations
STAT
MARCH 31, 2023
Indeed, academic inventors or founders contributed to more than one-quarter of all medicines approved from 2001 through 2019. Academia can be an excellent source of novel drug targets and new technologies that can enhance medicinal discovery. Yet many sponsored research collaborations that hope to tap into academia fail.
112 
Half of people worldwide at risk of developing mental health condition by age 75, per new study
STAT
AUGUST 8, 2023
The study, published last week in The Lancet Psychiatry , analyzed answers that participants provided between 2001 and 2022 in response to a World Health Organization survey designed to assess the prevalence of major mental health disorders.
98 
Minneceutics Newsletter
Blog: Ask a Student Pharmacist
OCTOBER 4, 2023
Minneceutics Newsletter eomizowh Wed, 10/04/2023 - 12:47 Current Newsletter Expand all + Archive 1993 1994 1995 1999 2000 2001 2002 2003 2004 2006 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021
52 
STAT+: Amgen’s $27.8 billion Horizon merger is latest industry bet on pricey rare disease drugs
STAT
DECEMBER 12, 2022
The deal is the largest pharma merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. Amgen said Monday it would purchase Horizon Pharmaceuticals for $27.8 Continue to STAT+ to read the full story…
Mistakes happen in research papers. But corrections often don’t
STAT
JANUARY 10, 2023
Five studies co-authored by Tessier-Lavigne are now under the microscope for containing alleged altered images: a 1999 Cell study , a 2008 paper in the EMBO Journal, a 2003 Nature study, and two studies published in 2001 in Science.
137 
STAT+: Departing Stanford president retracts two widely cited papers, against lead author’s wishes
STAT
AUGUST 31, 2023
The retractions come the same day that Tessier-Lavigne’s resignation as Stanford president takes effect.
143 
STAT+: Medicare may test policy of paying less for accelerated approval drugs
STAT
JANUARY 31, 2023
The program is widely considered a success and has worked well for many drugs, including the leukemia drug Gleevec , which the FDA approved in 2001 after a review period of just two-and-a-half months, based on study results that correctly predicted successful clinical outcomes. Continue to STAT+ to read the full story…
FDA 98
98 FDA 98
98 
FDA grants orphan drug status for Ichnos’ multiple myeloma antibody
Pharmaceutical Technology
JULY 10, 2023
The US FDA has granted orphan drug designation (ODD) for Ichnos Sciences’ ISB 2001 to treat patients with multiple myeloma.
FDA 52
52 FDA 52
52 
STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more
STAT
APRIL 11, 2024
stood at 323 during the fourth quarter of last year — the highest figure reached since such data began being tracked in 2001 — underscoring growing concerns about patient harm across the country, STAT tells us. Unresolved The number of ongoing and active drug shortages in the U.S.
Chemotherapy 108
108 
How telehealth startups are trying to fill the menopause care vacuum
STAT
JULY 17, 2023
The study was shut down early — and a year later, prescriptions had plummeted to nearly half what they had been in 2001. But in 2002, the therapy went into a free-fall when a landmark trial suggested treating menopause with estrogen and progesterone increased the risk of breast cancer and cardiovascular disease.
98 
College of Pharmacy Golf Classic
Blog: Ask a Student Pharmacist
JANUARY 9, 2024
College of Pharmacy Golf Classic eomizowh Tue, 01/09/2024 - 10:12 9:00am 5:00pm Midland Hills Country Club 2001 Fulham St Roseville MN 55113 Header Alignment Left Event Type In-Person This event is no longer available. View all of the Site Name Here events by visiting our Events page [link to events.umn.edu or events page on this website].
40 
STAT+: Pharmalittle: Amgen agrees to pay $27.8 billion for Horizon Therapeutics; Roche pharma head steps down
STAT
DECEMBER 12, 2022
The deal is the largest pharmaceutical merger announced this year, and it represents the most that Amgen has spent on an acquisition since its $16 billion purchase of Immunex in 2001. The The product is expected to generate $1.97 billion in 2022 and $2.26 billion in 2023, according to FactSet, an investment data firm.
98 
Huge inequalities found in access to myeloma clinical trials in Europe, says MPE
pharmaphorum
DECEMBER 1, 2022
Led by the MPE CEE Workgroup on Access, the report – Addressing access barriers to myeloma clinical trials in Central and Eastern Europe – evaluated the number of clinical trials held in CEE countries between 1 January 2001 and 28 September 2020. Approximately 50,000 people in Europe are diagnosed with myeloma each year.
72 
Prescribing Red Flags, Corresponding Responsibility and DEA Investigations: What’s a Pharmacist To Do?
The FDA Law Blog
FEBRUARY 19, 2023
Mr. Houck was a diversion investigator with the Drug Enforcement Administration (“DEA”) in the field and at agency headquarters for 15 years before joining HPM in 2001. at this year’s American Pharmacists Association’s (“APhA’s”) Annual Meeting in Phoenix, March 24-27.
Join Us for an HP&M Webinar – Demystifying DEA Inspections: Accountability Audits, Mirror Reviews and Mock Inspections (Wednesday, May 24: 12:00-12:45)
The FDA Law Blog
MAY 3, 2023
Before joining HP&M in 2001, Mr. Houck conducted numerous scheduled cyclic and targeted inspections and investigations as a DEA Diversion Investigator in the field for ten years. Registrants are far from powerless when DEA investigators inspect their controlled substance operations.
Join Us for an HPM Webinar: Recent Hospital Controlled Substance Diversion Cases — Cautionary Tales; Tuesday, October 3, 2023: 12:00-12:45
The FDA Law Blog
SEPTEMBER 12, 2023
In this webinar you’ll learn: How employees diverted controlled substances — their methods are constantly evolving What red flags were missed DEA inspection priorities Safeguards to minimize internal diversion Best practices for maximizing diversion detection Mr. Houck was a DEA Diversion Investigator for 15 years prior to joining HPM in 2001.
BrightPath Biotherapeutics Signs a Research and License Agreement with Artisan Bio to Advance Allogeneic iPSC Derived Cell Therapy Platform across Multiple Indications
PharmaShots
MAY 3, 2023
Additionally, high-throughput CRISPR editing is used by Artisan's SyionAI platform for novel drug discovery Ref: PR Newswire | Image: BrightPath Biotherapeutics Related News:- REGiMMUNE Entered into a License Agreement with San Fu Biotech to Develop and Commercialize RGI-2001 for the Prophylaxis of Acute Graft-Versus-Host Disease
40 
Reminder: HP&M Webinar on Recent Hospital Controlled Substance Diversion Cases — Cautionary Tales; Tuesday, October 3, 2023: 12:00-12:45
The FDA Law Blog
SEPTEMBER 26, 2023
In this webinar you’ll learn: How employees diverted controlled substances — their methods are constantly evolving What red flags were missed DEA inspection priorities Safeguards to minimize internal diversion Best practices for maximizing diversion detection Mr. Houck was a DEA Diversion Investigator for 15 years prior to joining HPM in 2001.
Roivant joins RNA splicing push with Eisai deal
pharmaphorum
JANUARY 6, 2022
H3B-8800 – now renamed RVT-2001 – will be taken in a slightly different direction by Roivant, which said it plans to develop it as a therapy for transfusion-dependent anaemia in patients with lower-risk MDS, according to the company.
Compounding 52
52 Compounding 52
52 
REMINDER: HP&M’s Webinar “Demystifying DEA Inspections: Accountability Audits, Mirror Reviews and Mock Inspections”
The FDA Law Blog
MAY 22, 2023
Before joining HP&M in 2001, Mr. Houck conducted numerous scheduled cyclic and targeted inspections and investigations as a DEA Diversion Investigator in the field for ten years. Registrants are far from powerless when DEA investigators inspect their controlled substance operations.
Bridging the healthcare digital divide: a gradual approach to adopting ePI
European Pharmaceutical Review
JANUARY 25, 2024
Proposal for a Directive of the European Parliament and of the Council on the Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC.” References European Commission, (26 April 2023). Article 63 EMA (29 January 2020). Article 63 Euractiv (26 September 2023).
Packaging 84
84 
Nuclear Pharmacist by Day, DJ by Night
Pharmacy Is Right For Me
OCTOBER 21, 2022
I worked in Dallas from 95-2001, then moved to NYC, then years later went to the University of Colorado for the NTPD program and received the PharmD. What makes your career path unique? My focus in Pharmacy School at OU was Nuclear Medicine. There was a fully operational Nuclear Pharmacy on campus, and I took all the courses.
Hospitals 130
130 
2022 spells change for EU pharmaceutical legislation
European Pharmaceutical Review
JUNE 24, 2022
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use. One of the key priorities of the EU’s strategy is to encourage innovation to solve unmet medical needs. Brussels; 2020.
Compounding 100
100 
GSK enters agreement with Canada for influenza vaccines
Pharmaceutical Technology
JULY 18, 2022
The latest contract comes after previous agreements between the parties for seasonal influenza and pandemic vaccines dating back to 2001. The company intends to supply both vaccines from its 230,000ft² Sainte-Foy facility in Quebec. .
Vaccines 64
64 
UVB phototherapy for atopic eczema does not increase skin cancer risk, says study
Hospital Pharmacy Europe
JUNE 12, 2023
The team undertook a nationwide, population-based cohort study from 2001-18 to estimate the risk of developing both non-melanoma skin cancer and melanoma. They excluded patients under 20 years of age, those with a prior diagnosis of skin cancer and individuals who had received PUVA therapy.
Hospitals 52
52 Hospitals 52
52 
Envision acquires commercial solutions firm Two Labs
pharmaphorum
NOVEMBER 18, 2020
Since being founded in 2001, Envision has delivered strong year-on-year organic growth and established leadership in medical affairs strategy, medical communications, and enterprise-wide Envision technology.
James Cloyd III, Receives Distinguished Tyler Prize
Blog: Ask a Student Pharmacist
JANUARY 29, 2020
The award was established in 1962 as the Stimulation of Research Award and was renamed The Tyler Prize for Stimulation of Research in 2002 in recognition of the distinguished scientific and administrative career of Dr. Varro "Tip" Tyler (1926-2001).
52 
Dog Owners Get Survival Benefit
The People's Pharmacy
MAY 10, 2023
Studying Dog Owners: The study was conducted in Sweden between 2001 and 2012 and included more than 300,000 individuals who had experienced a stroke or a heart attack ( Circulation: Cardiovascular Quality and Outcomes , Oct.
Vaccines 81
81 Vaccines 81
81 
W20 acquires data technology firms Swoop and IPM.ai
pharmaphorum
JANUARY 13, 2021
W20 was founded in 2001 by Jim Weiss and now employs 1,500 people, using analytics and technology to build insights for clients in the life sciences industry. W20 has been on the acquisition trail since it announced a partnership with New Mountain Capital in 2019. The post W20 acquires data technology firms Swoop and IPM.ai
52 
Did You Catch HMPV Recently Without Knowing It?
The People's Pharmacy
JUNE 1, 2023
Discovered in 2001, HMPV is in the Pneumoviridae family along with respiratory syncytial virus (RSV).” ” What jumps out for me is that this virus was only “discovered” in 2001 by Dutch researchers. That means a lot of healthcare providers probably never learned about it in school.
Vaccines 71
71 
Psychedelic medicines: are they gaining traction in Europe?
European Pharmaceutical Review
APRIL 13, 2023
For example, the relaxed attitude towards cannabis in the Netherlands is well-known and Portugal has decriminalised the possession and consumption of all illicit substances since 2001.
Will Aspirin Prevent Sunburn?
The People's Pharmacy
JUNE 5, 2023
Some Scientists Agree That Aspirin Helps Prevent Sunburn: Relatively little research has been done, but a German study found that pretreatment with 250 mg of aspirin prevented sunburn ( Photochemistry and Photobiology , Oct., That’s a lot lower than the dose you take, which could cause serious stomach damage.
65 
List of Top 10 PCD Pharma Companies in India
Fossil Remedies
JUNE 18, 2020
It is PCD pharma company in India associated with the pharmaceutical industry from the year 2001 and having headquarters in Ahmedabad. Spica Lab was established in 2001 with prime focus on enhancing and improving life with a feeling of wholesome and well-being for a better tomorrow.
Ibuprofen for chickenpox – can you use it? [ANSWERED]
Druggist
NOVEMBER 13, 2020
2001) was similar to the previously discussed research. 2001 May;107(5):1108-15. Additionally, it was suggested more research is needed to check the role of ibuprofen in getting NF. Study 2 – do NSAIDs increase the risk of infections in children with chickenpox . The objective of this study (Lesko et al., Pediatrics. doi: 10.1542/peds.107.5.1108.
Hospitals 98
98 Hospitals 98
98 
Is It Safe to Take Alli for a Long Time?
The People's Pharmacy
MARCH 27, 2023
.” Most clinical trials were fairly short, on the order of six months. Some lasted twice that long with no undue effects appearing other than digestive distress ( International Journal of Obesity and Related Metabolic Disorders , Nov. A daily multiple vitamin might be a good idea to reduce this potential complication.
FDA 58
58 FDA 58
58 
PharmaShots Weekly Snapshots (April 03 - 07, 2023)
PharmaShots
APRIL 7, 2023
TG Therapeutics Receives EMA’s CHMP Positive Opinion of Briumvi (ublituximab-xiiy) for the Treatment of Relapsing Forms of Multiple Sclerosis Date: Apr 3, 2023 | Tags: TG Therapeutics, Briumvi, Ublituximab-xiiy, Multiple Sclerosis, Regulatory, EMA, CHMP BMS Receives EMA’s CHMP Positive Opinion of Breyanzi (lisocabtagene maraleucel) for (..)
FDA 53
53 
Let's personalize your content